AdaptHealth
AHCO
149 hedge funds and large institutions have $1.68B invested in AdaptHealth in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 24 closing their positions.
146% more call options, than puts
Call options by funds: $23.7M | Put options by funds: $9.65M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
10% more capital invested
Capital invested by funds: $1.52B → $1.68B (+$154M)
10% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 50
4% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 24
1.59% less ownership
Funds ownership: 70.95% → 69.37% (-1.6%)
3% less funds holding
Funds holding: 154 → 149 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.6M |
| 2 |
RP
Reinhart Partners
Mequon,
Wisconsin
|
+$20.6M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$14.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.9M |
| 5 |
SC
SkyKnight Capital
San Francisco,
California
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$86.4M |
| 2 |
DM
Deerfield Management
New York
|
-$8.11M |
| 3 |
AC
Armistice Capital
New York
|
-$8.02M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.96M |
| 5 |
RP
Repertoire Partners
New York
|
-$7.96M |
AHCO Hedge Fund Activity: Q2 2022 in Review
149 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2022, worth a combined $1.68B — up 10% from $1.52B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of AHCO and 23 opened new positions — a net loss of 1 holder — while 50 trimmed existing stakes and 55 added.
The largest buyer was Fidelity Investments, adding an estimated $30.6M. The largest seller was Morgan Stanley, cutting an estimated $86.4M.
- 149 institutional investors held AdaptHealth (AHCO) as of Q2 2022, down from 154 in Q1 2022.
- Funds reported $1.68B of AdaptHealth stock for Q2 2022, up 10% quarter-over-quarter.
- 23 funds opened new AdaptHealth positions in Q2 2022 and 24 closed out, a net change of -1 holder.
- The largest AdaptHealth buyer in Q2 2022 was Fidelity Investments, an estimated $30.6M added.
- The largest AdaptHealth seller in Q2 2022 was Morgan Stanley, an estimated $86.4M sold.
Based on aggregated 13F filings for Q2 2022.